01:14
ISoP Connect- Getting Started
02:23:16
Understanding the Impact of Study Design the Role of Model-Informed Development on Dosage Selection
01:00:56
Maximizing on Minimal Data using Pharmacometric Modeling to Estimate the Prob. of Technical Success
56:56
Overview of CDISC ADaM Population PK Data Standard ADPPK Implementation Guide
58:04
Handling missing covariates in model-based meta-analysis (Use-case for competitive benchmarking)
01:12:56
Changes to Population PK/PD data and supplemental information based on FDA Guidance for PopPK
48:32
The DEM Method for Evaluating Surrogate Endpoints for Accelerated Clinical Development
01:04:03
Importance of Cultural Sensitivity in Transforming R&D in an International Company
56:54
Three Minute Thesis & Beyond! Short and Effective Technical Communication
59:39
Communicating the Influence Drug Development and Regulatory Decisions: A Tutorial
01:03:20
Science Through Story Telling with Dr. Sara ElShafie
57:43
Evaluation of covariate effects using forest plots and introduction to the coveffectsplot R package
51:13
A Gentle Introduction to Optimal Design for Pharmacometric Models
01:24:54
Estimands and Causal Inference in Pharmacometrics
51:52
ADA/Immunogenicity Data Handling
49:37
Review of proposed NCA ADAM standard
48:46
Update on CDISC ADaM Population PK Data Standard ADPPK
01:05:03
The Art and Science of Career Advancement Part 2
17:58
The Art and Science of Career Advancement Part 1
59:39
Communicating to Influence Drug Development and Regulatory Decisions: A Tutorial
59:30
Communicating in the Time of COVID
01:26:32
Introduction to MBMA
24:45
The Case of the Crisis of Confidence
13:36
The Case of the Pharmacometrician’s Pitiful Planning
11:59
The Case of the Extrapolated Prediction
23:16
The Case of the Not So Confirmatory Conclusion
40:34
Use of Berkeley Madonna For QSP Modeling (Dr. Yasong Lu)
X
About
The International Society of Pharmacometrics (www.go-isop.org) goal is to promote and advance the discipline of Pharmacometrics and broaden its impact.
(ISoP) seeks the promotion and advancement of the discipline of pharmacometrics, through Integration, Innovation, and Impact: quantitative integration of multisource data and knowledge of clinical, biomedical, biological, engineering, statistical, and mathematical concepts, resulting in continuous methodological and technological innovation enhancing scientific understanding and knowledge, which in turn has an impact on discovery, research, development, approval, and utilization of new therapies.
www.go-isop.org/
Tags